146 related articles for article (PubMed ID: 35090306)
21. Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Bzhalava Z; Arroyo Mühr LS; Dillner J
Vaccine; 2020 May; 38(25):4066-4070. PubMed ID: 32362526
[TBL] [Abstract][Full Text] [Related]
22. Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences.
de Villiers EM; Gunst K; Stein H; Scherübl H
Int J Cancer; 2004 Mar; 109(2):253-8. PubMed ID: 14750177
[TBL] [Abstract][Full Text] [Related]
23. DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers.
Ekanayake Weeramange C; Tang KD; Vasani S; Langton-Lockton J; Kenny L; Punyadeera C
Cells; 2020 May; 9(6):. PubMed ID: 32486347
[TBL] [Abstract][Full Text] [Related]
24. Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes.
Zhu X; Li S; Luo J; Ying X; Li Z; Wang Y; Zhang M; Zhang T; Jiang P; Wang X
Front Immunol; 2022; 13():801639. PubMed ID: 35126391
[TBL] [Abstract][Full Text] [Related]
25. Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures.
Zhang Y; Koneva LA; Virani S; Arthur AE; Virani A; Hall PB; Warden CD; Carey TE; Chepeha DB; Prince ME; McHugh JB; Wolf GT; Rozek LS; Sartor MA
Clin Cancer Res; 2016 Sep; 22(18):4735-45. PubMed ID: 27091409
[TBL] [Abstract][Full Text] [Related]
26. Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies.
Spiotto MT; Taniguchi CM; Klopp AH; Colbert LE; Lin SH; Wang L; Frederick MJ; Osman AA; Pickering CR; Frank SJ
Semin Radiat Oncol; 2021 Oct; 31(4):274-285. PubMed ID: 34455983
[TBL] [Abstract][Full Text] [Related]
27. The exploration of new therapeutic targets for HPV-negative head and neck squamous cell cancer through the construction of a ceRNA network and immune microenvironment analysis.
Wang Z; Liu T; Li G; Cao Z
J Cell Biochem; 2020 Jun; 121(5-6):3426-3437. PubMed ID: 31898341
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of key genes and signal pathways of human papilloma virus-related head and neck squamous cell carcinoma].
Wang KP; Yuan YJ; Zhu JQ; Li BL; Zhang TT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):571-577. PubMed ID: 32842349
[No Abstract] [Full Text] [Related]
29. Human Papilloma Virus Increases ΔNp63α Expression in Head and Neck Squamous Cell Carcinoma.
Citro S; Bellini A; Medda A; Sabatini ME; Tagliabue M; Chu F; Chiocca S
Front Cell Infect Microbiol; 2020; 10():143. PubMed ID: 32322564
[TBL] [Abstract][Full Text] [Related]
30. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
[TBL] [Abstract][Full Text] [Related]
31. Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC.
Gui S; O'Neill WQ; Teknos TN; Pan Q
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737336
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus Status and the Risk of Cerebrovascular Events Following Radiation Therapy for Head and Neck Cancer.
Addison D; Seidelmann SB; Janjua SA; Emami H; Staziaki PV; Hallett TR; Szilveszter B; Lu MT; Cambria RP; Hoffmann U; Chan AW; Wirth LJ; Neilan TG
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855164
[TBL] [Abstract][Full Text] [Related]
33. Proteomic study of HPV-positive head and neck cancers: preliminary results.
Descamps G; Wattiez R; Saussez S
Biomed Res Int; 2014; 2014():430906. PubMed ID: 24719866
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of significant genes and immune cell infiltration in HPV-related head and neck squamous cell carcinoma.
Xu L; Jin Y; Qin X
Int Immunopharmacol; 2020 Oct; 87():106844. PubMed ID: 32738592
[TBL] [Abstract][Full Text] [Related]
35. Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma.
Tian G; Fu Y; Zhang D; Li J; Zhang Z; Yang X
Cancer Cell Int; 2021 Mar; 21(1):167. PubMed ID: 33712015
[TBL] [Abstract][Full Text] [Related]
36. Integrative analysis in head and neck cancer reveals distinct role of miRNome and methylome as tumour epigenetic drivers.
Mandić K; Milutin Gašperov N; Božinović K; Dediol E; Krasić J; Sinčić N; Grce M; Sabol I; Barešić A
Sci Rep; 2024 Apr; 14(1):9062. PubMed ID: 38643268
[TBL] [Abstract][Full Text] [Related]
37. Next generation sequencing and its applications in HPV-associated cancers.
Tuna M; Amos CI
Oncotarget; 2017 Jan; 8(5):8877-8889. PubMed ID: 27784002
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer.
Smith EM; Ritchie JM; Summersgill KF; Hoffman HT; Wang DH; Haugen TH; Turek LP
J Natl Cancer Inst; 2004 Mar; 96(6):449-55. PubMed ID: 15026470
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of head and neck cancer.
Rettig EM; D'Souza G
Surg Oncol Clin N Am; 2015 Jul; 24(3):379-96. PubMed ID: 25979389
[TBL] [Abstract][Full Text] [Related]
40. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
Snietura M; Brewczynski A; Kopec A; Rutkowski T
Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
